ACST Stock Earnings: Acasti Pharma Beats EPS for Q1 2025

Date:

August 10, 2024

Acasti Pharma (NASDAQ:ACST) just reported results for the first quarter of 2025.

Acasti Pharma reported earnings per share of -24 cents. This was above the analyst estimate for EPS of -25 cents.
The company did not report any revenue for the quarter.

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

GETY Stock Earnings: Getty Images Holdings Misses EPS, Beats Revenue for Q2 2024

NGNE Stock Earnings: Neurogene Misses EPS for Q2 2024